KedRAB FDA Approval History
Last updated by Judith Stewart, BPharm on March 2, 2021.
FDA Approved: Yes (First approved August 23, 2017)
Brand name: KedRAB
Generic name: rabies immunoglobulin human
Dosage form: Injection
Company: Kamada Ltd. and Kedrion S.p.A.
Treatment for: Rabies Prophylaxis
KedRAB [rabies immunoglobulin (human)] is a human plasma derived anti-rabies immunoglobulin indicated for post-exposure prophylaxis (PEP) of rabies infection.
Development timeline for KedRAB
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.